Li Guangqi, Li Yanning, Chu Yuankui, Zhang Aijun, Pan Junfei, Wang Hongxia, Xu Guangxian
Department of Laboratory Medicine, Clinical Medical College, Ningxia Medical University, Yinchuan 750004, China.
Department of Laboratory Medicine, Clinical Medical College, Ningxia Medical University, Yinchuan 750004, China. *Corresponding author, E-mail:
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020 Nov;36(11):1036-1043.
Objective To construct and verify camelidae natural nanobody phage display library for selection of nanobodies against various antigens, and to obtain and identify the nanobody targeting CD19. Methods The total RNA of spleen of Bactrian camel was reverse transcribed and the variable region gene fragment of its heavy chain was obtained by nested PCR. It was constructed into the pCANTAB5e phagemid vector and electrotransformed into TG1 E. coli to develop the natural nanobody phage display library. After rescued by the KM13 helper phage, its capacity and diversity were analyzed and identified. Nanobody against CD19 was screened using biotinylated antigen combined with streptavidin magnetic beads, followed by ELISA, sequencing, exogenous expression and verification. Results The constructed natural phage nanobody display library had great diversity, and its fragment insertion rate was about 100%. The amino acid homology of 20 randomly selected clones was 65.85%, and the titer of the display library rescued by the helper phage was 9.0×10 CFU/mL. After panning with CD19 as the antigen, the positive clones were sequenced and analyzed, and finally anti-CD19 nanobody sequences were obtained. The exogenously expressed anti-CD19 nanobody based on the sequences was verified having the ability to bind to CD19. Conclusion A camelidae natural nanobody phage display library with high titer and great diversity has been successfully constructed. Three anti-CD19 nanobody sequences have been obtained by panning with CD19. In addition, this study provides technical support for researching and developing diagnostic kits and antibody drugs targeting CD19, and it is a novel direction to improve CAR-T cells targeting CD19.
目的 构建并验证用于筛选针对各种抗原的纳米抗体的骆驼科天然纳米抗体噬菌体展示文库,并获得和鉴定靶向CD19的纳米抗体。方法 对双峰驼脾脏的总RNA进行反转录,通过巢式PCR获得其重链可变区基因片段。将其构建到pCANTAB5e噬菌粒载体中,并电转化到TG1大肠杆菌中构建天然纳米抗体噬菌体展示文库。经KM13辅助噬菌体拯救后,对其库容和多样性进行分析鉴定。利用生物素化抗原结合链霉亲和素磁珠筛选针对CD19的纳米抗体,随后进行ELISA、测序、外源表达及验证。结果 构建的天然噬菌体纳米抗体展示文库具有高度多样性,片段插入率约为100%。随机选取20个克隆的氨基酸同源性为65.85%,辅助噬菌体拯救后的展示文库滴度为9.0×10 CFU/mL。以CD19为抗原进行淘选后,对阳性克隆进行测序分析,最终获得抗CD19纳米抗体序列。基于该序列外源表达的抗CD19纳米抗体经验证具有与CD19结合的能力。结论 成功构建了一个高滴度、高度多样性的骆驼科天然纳米抗体噬菌体展示文库。通过以CD19进行淘选获得了3条抗CD19纳米抗体序列。此外,本研究为研发靶向CD19的诊断试剂盒和抗体药物提供了技术支持,是改善靶向CD19的嵌合抗原受体T细胞的新方向。